Tech Update: A new approach to Alzheimer’s and proof that video calls are exhausting

Small Canadian biotech start-up Treventis is playing in the big leagues. The Toronto company just secured a partnership with Takeda, Japan’s largest drug maker, to help develop a new therapy for Alzheimer’s. There’s still uncertainty around the causes of Alzheimer’s, but misfolding of a protein called tau is thought to play an important role. It is believed […]

Share this page

#pf-body .pf-caption img.blockImage { margin: 0!important; float: none; } #pf-body a.elementor-icon, #pf-body a.skip-link{display:none!important;} /*#pf-content {max-width:100%!important}*/ #pf-content img.mediumImage, #pf-content figure.mediumImage { margin-left: auto!important; margin-right: auto!important; clear: both!important; float: none!important; display: block!important; }